Rem3dy Health has secured €16m to support growth and expansion into key international markets.
The Birmingham-based health tech scale-up, parent company of personalised nutrition brand Nourished, said the fundraise is worth around £14m.
The round was led by global strategic investors including Suntory, Estrella Galicia, Apollo Hospitals and UPSA, while investment from Birmingham’s Future Planet Capital Regional further signals the company’s regional roots.
“Securing this funding marks a major milestone for us. Following a year of significant transformation and against one of the toughest fundraising environments in recent years, we are now in a strong position to scale globally,” said Melissa Snover, founder and chief executive of Rem3dy Health.
The company aims to use the funds to enter key international markets including the US, MENA region and India.
It said the funding will also support a move into personalised health products for pets.
The fundraise forms part of €148.2m of disclosed funding invested in health tech, preventive health, digital care and patient-facing care in 2026, according to Health Tech World coverage.
The UK has been particularly active in these areas, with London-based start-ups Semble, JAAQ and Calibre closing significant funding rounds in recent months.
While Rem3dy Health’s focus on AI-driven personalised nutrition and advanced manufacturing is more consumer wellness-led than many healthcare delivery platforms, the round fits a wider 2026 pattern of investors backing data, automation and personalisation in health-related services.
“We are delighted to see Rem3dy Health continue to attract significant backing to fuel their already impressive growth,” said Rupert Lyle, investment director at Future Planet Capital Regional and fund principal of the West Midlands Co-Investment Fund.
“When we first invested in Rem3dy, it was clear they were developing a truly disruptive brand and technology capable of revolutionising the global wellness industry.”
Founded in 2019, Rem3dy Health uses AI-driven personalised nutrition and advanced manufacturing, combining data science, 3D printing and automation to deliver tailored health products at scale.
AI, or artificial intelligence, is software that can analyse data and identify patterns. 3D printing is a manufacturing method that builds products layer by layer.
The company said the investment highlights a broader strategic shift, with global consumer and healthcare players increasingly backing next-generation health technology businesses.
Rem3dy Health said Estrella Galicia’s participation is said to signal expansion beyond traditional categories, while Apollo Hospitals is said to bring expertise from one of the world’s largest integrated healthcare providers
